Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions - The Atherosclerosis Risk in Communities (ARIC) Study

被引:744
作者
Sharrett, AR
Ballantyne, CM
Coady, SA
Heiss, G
Sorlie, PD
Catellier, D
Patsch, W
机构
[1] NHLBI, Epidemiol & Biometry Program, NIH, DECA, Bethesda, MD 20892 USA
[2] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[3] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA
[4] Landeskrankenanstalten Salzburg, Dept Lab Med, Salzburg, Austria
关键词
lipoproteins; apolipoproteins; coronary disease; follow-up studies;
D O I
10.1161/hc3501.095214
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Despite consensus on the need for blood cholesterol reductions to prevent coronary heart disease (CHD), available evidence on optimal cholesterol levels or the added predictive value of additional lipids is sparse. Methods and Results-After 10 years follow-up of 12 339 middle-aged participants free of CHD in the Atherosclerosis Risk in Communities Study (ARIC), 725 CHD events occurred. The lowest incidence was observed in those at the lowest LDL cholesterol (LDL-C) quintile, with medians of 88 mg/dL in women and 95 mg/dL in men, and risk accelerated at higher levels, with relative risks (RRs) for the highest quintile of 2.7 in women and 2.5 in men. LDL-C, HDL-C, lipoprotein(a) [Lp(a)], and in women but not men, triglycerides (TG) were all independent CHD predictors, providing an RR, together with blood pressure, smoking, and diabetes, of 13.5 in women and 4.9 in men. Lp(a) was less significant in blacks than whites. Prediction was not enhanced by HDL-C density subfractions or apolipoproteins (apo) A-I or B. Despite strong univariate associations, apoB did not contribute to risk prediction in subgroups with elevated TG, with lower LDL-C, or with high apoB relative to LDL-C. Conclusions-Optimal LDL-C values are <100 mg/dL in both women and men. LDL-C, HDL-C, TG, and Lp(a), without additional apolipoproteins or lipid subfractions, provide substantial CHD prediction, with much higher RR in women than men.
引用
收藏
页码:1108 / 1113
页数:6
相关论文
共 50 条
  • [31] Associations of circulating proteins with lipoprotein profiles: proteomic analyses from the OmniHeart randomized trial and the Atherosclerosis Risk in Communities (ARIC) Study
    Hyunju Kim
    Alice H. Lichtenstein
    Peter Ganz
    Edgar R. Miller
    Josef Coresh
    Lawrence J. Appel
    Casey M. Rebholz
    Clinical Proteomics, 2023, 20
  • [32] β-fibrinogen gene-455G/A polymorphism and coronary heart disease incidence:: The Atherosclerosis Risk in Communities (ARIC) Study
    Folsom, AR
    Aleksic, N
    Ahn, C
    Boerwinkle, E
    Wu, KK
    ANNALS OF EPIDEMIOLOGY, 2001, 11 (03) : 166 - 170
  • [33] Lack of association of plasma factor XI with incident stroke and coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study
    Folsom, Aaron R.
    George, Kristen M.
    Appiah, Duke
    ATHEROSCLEROSIS, 2015, 243 (01) : 181 - 185
  • [34] Weighing in before the fight - Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy
    Denke, MA
    CIRCULATION, 2005, 112 (22) : 3368 - 3370
  • [35] Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins - The atherosclerosis risk in communities (ARIC) study
    Folsom, AR
    Nieto, FJ
    McGovern, PG
    Tsai, MY
    Malinow, MR
    Eckfeldt, JH
    Hess, DL
    Davis, CE
    CIRCULATION, 1998, 98 (03) : 204 - 210
  • [36] Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study
    Ren, Xiaomei
    Wang, Xia
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, : 1175 - 1181
  • [37] Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS)
    Williams, K
    Sniderman, AD
    Sattar, N
    D'Agostino, R
    Wagenknecht, LE
    Haffner, SM
    CIRCULATION, 2003, 108 (19) : 2312 - 2316
  • [38] Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglyceride and Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study: Can Genetic Variants Provide New Insights on Triglycerides and Atherogenic Lipoproteins?
    Saeed, Anum
    Feofanova, Eleana
    Yu, Bing
    Virani, Salim S.
    Sun, Wensheng
    Nambi, Vijay
    Heiss, Gerardo
    Guild, Cameron S.
    Coresh, Josef
    Boerwinkle, Eric
    Ballantyne, Christie M.
    Hoogeveen, Ron
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [39] Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial)
    Kullo, Iftikhar J.
    Jouni, Hayan
    Austin, Erin E.
    Brown, Sherry-Ann
    Kruisselbrink, Teresa M.
    Isseh, Iyad N.
    Haddad, Raad A.
    Marroush, Tariq S.
    Shameer, Khader
    Olson, Janet E.
    Broeckel, Ulrich
    Green, Robert C.
    Schaid, Daniel J.
    Montori, Victor M.
    Bailey, Kent R.
    CIRCULATION, 2016, 133 (12) : 1181 - 1188
  • [40] Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
    Ballantyne, CM
    Hoogeveen, RC
    Bang, H
    Coresh, J
    Folsom, AR
    Heiss, G
    Sharrett, AR
    CIRCULATION, 2004, 109 (07) : 837 - 842